From July 1, 2022 to September 30, 2022, the company has repurchased 7,201,500 shares, representing 0.63% for CNY 102.22 million. With this, the company has completed the repurchase of 10,633,664 shares, representing 0.92% for CNY 151.61 million under the buyback announced on May 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.48 CNY | +0.28% | -0.28% | -4.36% |
May. 23 | Aodong Medicine Industry's Unit Gets Certificates for 10 Traditional Chinese Medicines | MT |
May. 20 | Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.36% | 2.39B | |
+40.73% | 739B | |
+31.87% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.68% | 240B | |
+9.47% | 210B | |
-4.95% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.